Answers are grounded in this paper and cite their sources.
Prevention is the key to reducing the vascular sequelae of diabetes. Prevention starts with good glycaemic control and continues with a comprehensive programme of risk modification, such as lipid-lowering therapy, antihypertensive treatment, and improved lifestyle. With regard to lipid modification, agents such as statins may provide additional, non-lipid effects in both the diabetic and non-diabetic patient. This review discusses recent studies supporting risk reduction, available treatments, and recommendations applicable to the diabetic patient.
No takes yet. Share an insight, caveat, or question.
Gavin et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: